Long-term (96 weeks) adefovir dipivoxil in HBeAg negative chronic hepatitis results in significant virological, biochemical and histological improvement.

被引：0

作者：

Hadziyannis, S

Tassopoulos, N

Heathcote, E

Chang, TT

Kitis, G

Rizzeto, M

Marcellin, P

Lim, SG

Chen, SS

Wulfsohn, M

Xiong, S

James, C

Currie, G

Brosgart, C

机构：

[1] Henry Dunant Hosp, Athens, M5T 2S8, Greece

[2] Western Attica Hosp, Athens, Greece

[3] Toronto Western Hosp, Toronto, ON, Canada

[4] Natl Cheng Kung Hosp, Taipei, Taiwan

[5] Georgios Papanikolaou Hosp, Thessaloniki, Greece

[6] Azienda Ospedaliera San Giovanni Battista, Turin 117548, Italy

[7] Hop Beaujon, Clichy, 94404, France

[8] Natl Univ Singapore, Singapore, Singapore

[9] Gilead Sci Inc, Foster City, CA USA

来源：

HEPATOLOGY | 2003年 / 38卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

241

引用

页码：273A / 273A

页数：1

共 50 条

[31] Adefovir dipivoxil (ADV) results in a consistent and significant improvement in liver histology and clinical status regardless of baseline Knodell fibrosis score in patients with HBeAg plus chronic hepatitis B
Marcellin, P
Chang, TT
Lim, SG
Tong, M
Sievert, W
Shiffman, M
Jeffers, L
Goodman, Z
Wulfsohn, M
Fallis, R
Fry, J
Brosgart, C
[J]. GASTROENTEROLOGY, 2003, 124 (04) : A714 - A714
[32] Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B A meta-analysis
Luo, Qing
Deng, Yong
Cheng, Feifei
Kang, Juan
Zhong, Shan
Zhang, Dazhi
Zeng, Weiqiong
[J]. MEDICINE, 2016, 95 (50) : e5578
[33] Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B
Kaymakoglu, Sabahattin
Danalioglu, Ahmet
Demir, Kadir
Karaca, Cetin
Akyuz, Filiz
Onel, Derya
Badur, Selim
Cevikbas, Ugur
Besisik, Fatih
Cakaloglu, Yilmaz
Okten, Atilla
[J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (03) : 727 - 731
[34] Long-Term Results of Interferon Alpha Monotherapy in Patients with HBeAg-Negative Chronic Hepatitis B
Sabahattin Kaymakoglu
Ahmet Danalioglu
Kadir Demir
Cetin Karaca
Filiz Akyuz
Derya Onel
Selim Badur
Ugur Cevikbas
Fatih Besisik
Yilmaz Cakaloglu
Atilla Okten
[J]. Digestive Diseases and Sciences, 2007, 52 : 727 - 731
[35] ADDITION OF ADEFOVIR DIPIVOXIL TO LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH YMDD MUTATION. THE LONG-TERM FOLLOW-UP RESULTS
Eyigun, Can P.
Gull, Honefi C.
Coskun, Omer
Gunal, Emine
Erdem, Hokon
Avci, Ismail Y.
Gorenek, Levent
Besir-Bellioglu, Bulent A.
Kubor, Ayhon
[J]. HEPATOLOGY, 2008, 48 (04) : 536A - 536A
[36] Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
Lee, Jung Min
Park, Jun Yong
Kim, Do Young
Nguyen, Tin
Hong, Sun Pyo
Kim, Soo Ok
Chon, Chae Yoon
Han, Kwang-Hyub
Ahn, Sang Hoon
[J]. ANTIVIRAL THERAPY, 2010, 15 (02) : 235 - 241
[37] LONG-TERM BIOCHEMICAL, VIROLOGICAL, AND HISTOLOGICAL FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON
TAKAHASHI, M
YAMADA, G
TSUGENO, H
ENDO, H
KISHI, F
TAKATANI, M
MANABE, K
MIZUNO, M
TSUJI, T
[J]. HEPATOLOGY, 1995, 22 (04) : 269 - 269
[38] Efficacy of long-term lamivudine therapy in HBeAg negative chronic hepatitis B
Dimou, E
Papatheodoridis, GC
Laras, A
Rapti, I
Dourakis, S
Hadziyannis, SJ
[J]. HEPATOLOGY, 1999, 30 (04) : 646A - 646A
[39] LONG-TERM ADEFOVIR DIPIVOXIL MONOTHERAPY FOR UP TO 5 YEARS IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B
Lee, Jung Min
Park, Jun Yong
Kim, Do Young
Nguyen, Tin
Hong, Sunpyo
Lee, Kwan Sik
Moon, Byung Soo
Han, Kwang-Hyub
Chon, Chae Yoon
Moon, Young Myoung
Ahn, Sang Hoon
[J]. HEPATOLOGY, 2009, 50 (04) : 504A - 504A
[40] Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
Kim, D. Y.
Lee, J. M.
Ahn, S. H.
Lee, Y. C.
Lee, D. K.
Chung, J. B.
Chon, C. Y.
Han, K-H
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176

← 1 2 3 4 5 →